Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 392

1.

Amyloid and cerebrovascular burden divergently influence brain functional network changes over time.

Chong JSX, Jang H, Kim HJ, Ng KK, Na DL, Lee JH, Seo SW, Zhou J.

Neurology. 2019 Sep 11. pii: 10.1212/WNL.0000000000008315. doi: 10.1212/WNL.0000000000008315. [Epub ahead of print]

PMID:
31511349
2.

Topographical Heterogeneity of Alzheimer's Disease Based on MR Imaging, Tau PET, and Amyloid PET.

Jeon S, Kang JM, Seo S, Jeong HJ, Funck T, Lee SY, Park KH, Lee YB, Yeon BK, Ido T, Okamura N, Evans AC, Na DL, Noh Y.

Front Aging Neurosci. 2019 Aug 20;11:211. doi: 10.3389/fnagi.2019.00211. eCollection 2019.

3.

Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.

Jang H, Kim HJ, Park S, Park YH, Choe Y, Cho H, Lyoo CH, Yoon U, Lee JS, Kim Y, Kim SJ, Kim JP, Jung YH, Ryu YH, Choi JY, Moon SH, Seong JK, DeCarli C, Weiner MW, Lockhart SN, Cho SH, Na DL, Seo SW.

Eur J Nucl Med Mol Imaging. 2019 Aug 31. doi: 10.1007/s00259-019-04498-y. [Epub ahead of print]

PMID:
31471715
4.

THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report.

Kim HJ, Cho H, Park S, Jang H, Ryu YH, Choi JY, Moon SH, Oh SJ, Oh M, Na DL, Lyoo CH, Kim EJ, Seeley WW, Kim JS, Choi KC, Seo SW.

BMC Neurol. 2019 Aug 29;19(1):211. doi: 10.1186/s12883-019-1434-z.

5.

Sex-specific relationship of cardiometabolic syndrome with lower cortical thickness.

Kim SE, Lee JS, Woo S, Kim S, Kim HJ, Park S, Lee BI, Park J, Kim Y, Jang H, Kim SJ, Cho SH, Lee B, Lockhart SN, Na DL, Seo SW.

Neurology. 2019 Sep 10;93(11):e1045-e1057. doi: 10.1212/WNL.0000000000008084. Epub 2019 Aug 23.

PMID:
31444241
6.

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers.

Jang H, Park J, Woo S, Kim S, Kim HJ, Na DL, Lockhart SN, Kim Y, Kim KW, Cho SH, Kim SJ, Seong JK, Seo SW; Alzheimer’s Disease Neuroimaging Initiative.

Neuroimage Clin. 2019 Jul 19;24:101941. doi: 10.1016/j.nicl.2019.101941. [Epub ahead of print]

7.

Development of wirelessly-powered, extracranial brain activator (ECBA) in a large animal model for the future non-invasive human neuromodulation.

Lee H, Lee JS, Chung Y, Chung WR, Kim SJ, Kang JS, Park SM, Kang W, Seo DW, Na DL, Shon YM.

Sci Rep. 2019 Jul 29;9(1):10906. doi: 10.1038/s41598-019-47383-2.

8.

Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T).

Jo H, Kim M, Park S, Park JE, Cho SH, Kim SJ, Jang H, Jung YH, Kim J, Na DL, Seo SW, Cho JW, Kim HJ.

J Alzheimers Dis. 2019;71(1):7-13. doi: 10.3233/JAD-190469.

PMID:
31322578
9.

The First Generation of iPSC Line from a Korean Alzheimer's Disease Patient Carrying APP-V715M Mutation Exhibits a Distinct Mitochondrial Dysfunction.

Li L, Roh JH, Kim HJ, Park HJ, Kim M, Koh W, Heo H, Chang JW, Nakanishi M, Yoon T, Na DL, Song J.

Exp Neurobiol. 2019 Jun;28(3):329-336. doi: 10.5607/en.2019.28.3.329. Epub 2019 May 14.

10.

Distinct Brain Regions in Physiological and Pathological Brain Aging.

Lee JS, Park YH, Park S, Yoon U, Choe Y, Cheon BK, Hahn A, Cho SH, Kim SJ, Kim JP, Jung YH, Park KC, Kim HJ, Jang H, Na DL, Seo SW.

Front Aging Neurosci. 2019 Jun 18;11:147. doi: 10.3389/fnagi.2019.00147. eCollection 2019.

11.

APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms.

Charidimou A, Zonneveld HI, Shams S, Kantarci K, Shoamanesh A, Hilal S, Yates PA, Boulouis G, Na HK, Pasi M, Biffi A, Chai YL, Chong JR, Wahlund LO, Clifford JR, Chen C, Gurol ME, Goldstein JN, Na DL, Barkhof F, Seo SW, Rosand J, Greenberg SM, Viswanathan A.

Neurology. 2019 Jul 23;93(4):e358-e371. doi: 10.1212/WNL.0000000000007818. Epub 2019 Jun 26.

PMID:
31243071
12.

Analysis of dementia-related gene variants in APOE ε4 noncarrying Korean patients with early-onset Alzheimer's disease.

Park JE, Kim HJ, Kim YE, Jang H, Cho SH, Kim SJ, Na DL, Won HH, Ki CS, Seo SW.

Neurobiol Aging. 2019 May 22. pii: S0197-4580(19)30144-7. doi: 10.1016/j.neurobiolaging.2019.05.009. [Epub ahead of print]

PMID:
31217084
13.

Machine learning based hierarchical classification of frontotemporal dementia and Alzheimer's disease.

Kim JP, Kim J, Park YH, Park SB, Lee JS, Yoo S, Kim EJ, Kim HJ, Na DL, Brown JA, Lockhart SN, Seo SW, Seong JK.

Neuroimage Clin. 2019;23:101811. doi: 10.1016/j.nicl.2019.101811. Epub 2019 Apr 3.

14.

Clinical Effects of Frontal Behavioral Impairment: Cortical Thickness and Cognitive Decline in Individuals with Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment.

Kim SJ, Jung NY, Kim YJ, Park SB, Kim K, Kim Y, Jang H, Kim SE, Cho SH, Kim JP, Jung YH, Woo SY, Kim SW, Lockhart SN, Kim EJ, Kim HJ, Lee JM, Chin J, Na DL, Seo SW.

J Alzheimers Dis. 2019;69(1):213-225. doi: 10.3233/JAD-190007.

PMID:
30958372
15.

Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.

Jang H, Jang YK, Kim HJ, Werring DJ, Lee JS, Choe YS, Park S, Lee J, Kim KW, Kim Y, Cho SH, Kim SE, Kim SJ, Charidimou A, Na DL, Seo SW.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1287-1298. doi: 10.1007/s00259-019-04314-7. Epub 2019 Apr 2.

PMID:
30937462
16.

Exposure to ambient fine particles and neuropsychiatric symptoms in cognitive disorder: A repeated measure analysis from the CREDOS (Clinical Research Center for Dementia of South Korea) study.

Lee H, Kang JM, Myung W, Choi J, Lee C, Na DL, Kim SY, Lee JH, Han SH, Choi SH, Kim SY, Cho SJ, Yeon BK, Kim DK, Lewis M, Lee EM, Kim CT, Kim H.

Sci Total Environ. 2019 Jun 10;668:411-418. doi: 10.1016/j.scitotenv.2019.02.447. Epub 2019 Mar 2.

PMID:
30852217
17.

Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease.

Franzmeier N, Rubinski A, Neitzel J, Kim Y, Damm A, Na DL, Kim HJ, Lyoo CH, Cho H, Finsterwalder S, Duering M, Seo SW, Ewers M; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2019 Apr 1;142(4):1093-1107. doi: 10.1093/brain/awz026.

PMID:
30770704
18.

Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals.

Jang H, Kang D, Chang Y, Kim Y, Lee JS, Kim KW, Jang YK, Kim HJ, Na DL, Shin HY, Kang M, Guallar E, Cho J, Seo SW.

Sci Rep. 2019 Feb 12;9(1):1814. doi: 10.1038/s41598-018-38357-x.

19.

Multimodal imaging analyses in patients with genetic and sporadic forms of small vessel disease.

Kim KW, Kwon H, Kim YE, Yoon CW, Kim YJ, Kim YB, Lee JM, Yoon WT, Kim HJ, Lee JS, Jang YK, Kim Y, Jang H, Ki CS, Youn YC, Shin BS, Bang OY, Kim GM, Chung CS, Kim SJ, Na DL, Duering M, Cho H, Seo SW.

Sci Rep. 2019 Jan 28;9(1):787. doi: 10.1038/s41598-018-36580-0.

20.

Cerebrospinal fluid from Alzheimer's disease patients as an optimal formulation for therapeutic application of mesenchymal stem cells in Alzheimer's disease.

Lee J, Kwon SJ, Kim JH, Jang H, Lee NK, Hwang JW, Kim JH, Chang JW, Na DL.

Sci Rep. 2019 Jan 24;9(1):564. doi: 10.1038/s41598-018-37252-9.

21.

Data-driven prognostic features of cognitive trajectories in patients with amnestic mild cognitive impairments.

Kim YJ, Cho SK, Kim HJ, Lee JS, Lee J, Jang YK, Vogel JW, Na DL, Kim C, Seo SW.

Alzheimers Res Ther. 2019 Jan 22;11(1):10. doi: 10.1186/s13195-018-0462-z.

22.

White Matter Network Disruption and Cognitive Dysfunction in Neuromyelitis Optica Spectrum Disorder.

Cho EB, Han CE, Seo SW, Chin J, Shin JH, Cho HJ, Seok JM, Kim ST, Kim BJ, Na DL, Lee KH, Seong JK, Min JH.

Front Neurol. 2018 Dec 17;9:1104. doi: 10.3389/fneur.2018.01104. eCollection 2018.

23.

18F-flortaucipir uptake patterns in clinical subtypes of primary progressive aphasia.

Cho H, Kim HJ, Choi JY, Ryu YH, Lee MS, Na DL, Seo SW, Lyoo CH.

Neurobiol Aging. 2019 Mar;75:187-197. doi: 10.1016/j.neurobiolaging.2018.11.017. Epub 2018 Nov 23.

PMID:
30594046
24.

Subcortical Ischemic Change as a Predictor of Driving Cessation in the Elderly.

Jang M, Hong CH, Kim HC, Choi SH, Seo SW, Kim SY, Na DL, Lee Y, Chang KJ, Roh HW, Son SJ.

Psychiatry Investig. 2018 Dec;15(12):1162-1167. doi: 10.30773/pi.2018.10.10.3. Epub 2018 Nov 26.

25.

The Brain Donation Program in South Korea.

Kim Y, Suh YL, Kim SJ, Bae MH, Kim JB, Kim Y, Choi KC, Huh GY, Kim EJ, Lee JS, Kang HW, Shim SM, Lim HJ, Koh YH, Kim BC, Lee KH, Lee MC, Lee HW, Lim TS, Seeley WW, Kim HJ, Na DL, Lee KH, Seo SW.

Yonsei Med J. 2018 Dec;59(10):1197-1204. doi: 10.3349/ymj.2018.59.10.1197.

26.

Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer's disease.

Jung NY, Han JC, Ong YT, Cheung CY, Chen CP, Wong TY, Kim HJ, Kim YJ, Lee J, Lee JS, Jang YK, Kee C, Lee KH, Kim EJ, Seo SW, Na DL.

J Neurol Sci. 2019 Jan 15;396:94-101. doi: 10.1016/j.jns.2018.10.025. Epub 2018 Oct 31.

PMID:
30447606
27.

iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia.

Li L, Roh JH, Chang EH, Lee Y, Lee S, Kim M, Koh W, Chang JW, Kim HJ, Nakanishi M, Barker RA, Na DL, Song J.

Exp Neurobiol. 2018 Oct;27(5):350-364. doi: 10.5607/en.2018.27.5.350. Epub 2018 Oct 31.

28.

Cortical atrophy pattern-based subtyping predicts prognosis of amnestic MCI: an individual-level analysis.

Kim HJ, Park JY, Seo SW, Jung YH, Kim Y, Jang H, Kim ST, Seong JK, Na DL.

Neurobiol Aging. 2019 Feb;74:38-45. doi: 10.1016/j.neurobiolaging.2018.10.010. Epub 2018 Oct 12.

PMID:
30415126
29.

Distinct amyloid distribution patterns in amyloid positive subcortical vascular cognitive impairment.

Jang H, Park JY, Jang YK, Kim HJ, Lee JS, Na DL, Noh Y, Lockhart SN, Seong JK, Seo SW.

Sci Rep. 2018 Nov 1;8(1):16178. doi: 10.1038/s41598-018-34032-3.

30.

Risk Factors of Behavioral and Psychological Symptoms in Patients with Alzheimer Disease: The Clinical Research of Dementia of South Korea Study.

Park S, Kim DK, Myung W, Yoo JH, Shin SJ, Na DL, Kim SY, Lee JH, Kim SY, Han SH, Choi SH, Shin J.

Korean J Fam Med. 2019 Jan;40(1):16-21. doi: 10.4082/kjfm.17.0061. Epub 2018 Oct 29.

31.

A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.

Kim SE, Woo S, Kim SW, Chin J, Kim HJ, Lee BI, Park J, Park KW, Kang DY, Noh Y, Ye BS, Yoo HS, Lee JS, Kim Y, Kim SJ, Cho SH, Na DL, Lockhart SN, Jang H, Seo SW.

J Alzheimers Dis. 2018;66(2):681-691. doi: 10.3233/JAD-180048.

PMID:
30320571
32.

The impact of education on cortical thickness in amyloid-negative subcortical vascular dementia: cognitive reserve hypothesis.

Jung NY, Cho H, Kim YJ, Kim HJ, Lee JM, Park S, Kim ST, Kim EJ, Kim JS, Moon SH, Lee JH, Ewers M, Na DL, Seo SW.

Alzheimers Res Ther. 2018 Sep 27;10(1):103. doi: 10.1186/s13195-018-0432-5.

33.

Biological Brain Age Prediction Using Cortical Thickness Data: A Large Scale Cohort Study.

Aycheh HM, Seong JK, Shin JH, Na DL, Kang B, Seo SW, Sohn KA.

Front Aging Neurosci. 2018 Aug 22;10:252. doi: 10.3389/fnagi.2018.00252. eCollection 2018.

34.

Trajectories of Physiological Brain Aging and Related Factors in People Aged from 20 to over-80.

Lee JS, Kim S, Yoo H, Park S, Jang YK, Kim HJ, Kim KW, Kim Y, Jang H, Park KC, Yaffe K, Yang JJ, Lee JM, Na DL, Seo SW.

J Alzheimers Dis. 2018;65(4):1237-1246. doi: 10.3233/JAD-170537.

PMID:
30149442
35.

Vascular Effects on Depressive Symptoms in Cognitive Impairment.

Kim Y, Jang H, Kim SJ, Cho SH, Kim SE, Kim ST, Kim HJ, Moon SH, Ewers M, Im K, Kwon H, Na DL, Seo SW.

J Alzheimers Dis. 2018;65(2):597-605. doi: 10.3233/JAD-180394.

PMID:
30056427
36.

Sex-Related Reserve Hypothesis in Alzheimer's Disease: Changes in Cortical Thickness with a Five-Year Longitudinal Follow-Up.

Lee J, Cho H, Jeon S, Kim HJ, Kim YJ, Lee J, Kim ST, Lee JM, Chin J, Lockhart SN, Lee AY, Na DL, Seo SW.

J Alzheimers Dis. 2018;65(2):641-649. doi: 10.3233/JAD-180049.

PMID:
30056418
37.

Analysis of frontotemporal dementia, amyotrophic lateral sclerosis, and other dementia-related genes in 107 Korean patients with frontotemporal dementia.

Kim EJ, Kim YE, Jang JH, Cho EH, Na DL, Seo SW, Jung NY, Jeong JH, Kwon JC, Park KH, Park KW, Lee JH, Roh JH, Kim HJ, Yoon SJ, Choi SH, Jang JW, Ki CS, Kim SH.

Neurobiol Aging. 2018 Dec;72:186.e1-186.e7. doi: 10.1016/j.neurobiolaging.2018.06.031. Epub 2018 Jun 30.

PMID:
30054184
38.

Prediction Models of Cognitive Trajectories in Patients with Nonamnestic Mild Cognitive Impairment.

Lee JS, Cho SK, Kim HJ, Kim YJ, Park KC, Lockhart SN, Na DL, Kim C, Seo SW.

Sci Rep. 2018 Jul 11;8(1):10468. doi: 10.1038/s41598-018-28881-1.

39.

Social Event Memory Test (SEMT): A Video-based Memory Test for Predicting Amyloid Positivity for Alzheimer's Disease.

Kim KW, Choi JD, Lee H, Lee NK, Park S, Chin J, Lee BH, Shin J, Kim Y, Jang H, Choi JH, Na DL.

Sci Rep. 2018 Jul 10;8(1):10421. doi: 10.1038/s41598-018-28768-1.

40.

Amyloid involvement in subcortical regions predicts cognitive decline.

Cho SH, Shin JH, Jang H, Park S, Kim HJ, Kim SE, Kim SJ, Kim Y, Lee JS, Na DL, Lockhart SN, Rabinovici GD, Seong JK, Seo SW; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2368-2376. doi: 10.1007/s00259-018-4081-5. Epub 2018 Jul 6.

PMID:
29980831
41.

Pathologically Confirmed Cerebral Amyloid Angiopathy with No Radiological Sign in a Patient with Early Onset Alzheimer's Disease.

Kim SJ, Seo Y, Kim HJ, Na DL, Seo SW, Kim Y, Suh YL.

Yonsei Med J. 2018 Aug;59(6):801-805. doi: 10.3349/ymj.2018.59.6.801.

42.

Age-Specific Cutoff Scores on a T1-Weighted Axial Medial Temporal-Lobe Atrophy Visual Rating Scale in Alzheimer's Disease Using Clinical Research Center for Dementia of South Korea Data.

Choi GS, Kim GH, Choi JH, Hwang J, Kwon E, Lee SA, Kong KA, Kang HJ, Yoon B, Kim BC, Yang DW, Na DL, Kim EJ, Na HR, Han HJ, Lee JH, Kim JH, Lee KY, Park KH, Park KW, Kim S, Han SH, Kim SY, Yoon SJ, Moon SY, Youn YC, Choi SH, Jeong JH.

J Clin Neurol. 2018 Jul;14(3):275-282. doi: 10.3988/jcn.2018.14.3.275.

43.

Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial.

Yoon BK, Chin J, Kim JW, Shin MH, Ahn S, Lee DY, Seo SW, Na DL.

Menopause. 2018 Aug;25(8):870-876. doi: 10.1097/GME.0000000000001140.

PMID:
29846283
44.

Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.

Banerjee G, Jang H, Kim HJ, Kim ST, Kim JS, Lee JH, Im K, Kwon H, Lee JM, Na DL, Seo SW, Werring DJ.

J Alzheimers Dis. 2018;63(4):1485-1497. doi: 10.3233/JAD-170943.

PMID:
29843234
45.

Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.

Kim HJ, Park S, Cho H, Jang YK, San Lee J, Jang H, Kim Y, Kim KW, Ryu YH, Choi JY, Moon SH, Weiner MW, Jagust WJ, Rabinovici GD, DeCarli C, Lyoo CH, Na DL, Seo SW.

JAMA Neurol. 2018 Aug 1;75(8):999-1007. doi: 10.1001/jamaneurol.2018.0975.

46.

Increased Uptake of AV-1451 in a Subacute Infarction Lesion.

Cho SH, Cho H, Park S, Ryu YH, Choi JY, Lyoo CH, Na DL, Seo SW, Kim HJ.

Yonsei Med J. 2018 Jun;59(4):563-565. doi: 10.3349/ymj.2018.59.4.563.

47.

Atrophy patterns in cerebral amyloid angiopathy with and without cortical superficial siderosis.

Kim J, Na HK, Shin JH, Kim HJ, Seo SW, Seong JK, Na DL.

Neurology. 2018 May 15;90(20):e1751-e1758. doi: 10.1212/WNL.0000000000005524. Epub 2018 Apr 20.

PMID:
29678935
48.

Longitudinal outcomes of amyloid positive versus negative amnestic mild cognitive impairments: a three-year longitudinal study.

Ye BS, Kim HJ, Kim YJ, Jung NY, Lee JS, Lee J, Jang YK, Yang JJ, Lee JM, Vogel JW, Na DL, Seo SW.

Sci Rep. 2018 Apr 3;8(1):5557. doi: 10.1038/s41598-018-23676-w.

49.

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleo A, Molinuevo JL, Jagust WJ, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimalla R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon MJ, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R.

Alzheimers Dement. 2018 Jul;14(7):913-924. doi: 10.1016/j.jalz.2018.02.009. Epub 2018 Mar 28.

PMID:
29601787
50.

Preoperative biomarkers in patients with idiopathic normal pressure hydrocephalus showing a favorable shunt surgery outcome.

Hong YJ, Kim MJ, Jeong E, Kim JE, Hwang J, Lee JI, Lee JH, Na DL.

J Neurol Sci. 2018 Apr 15;387:21-26. doi: 10.1016/j.jns.2018.01.017. Epub 2018 Jan 16.

PMID:
29571865

Supplemental Content

Loading ...
Support Center